Lane Johnson was selected the No. 1 offensive tackle in a preseason survey by The Associated Press. A panel of eight AP Pro ...

The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...

WASHINGTON – House Speaker Mike Johnson said he thinks the Trump administration should release all the records in its ...

Johnson & Johnson revised its fiscal year 2025 guidance. The company expects adjusted earnings of $10.80-$10.90, up from ...

How many games will the Bears win? How did readers grade the brass? Which position concerns them most? Check out our sixth ...

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...

Johnson & Johnson has slashed on Wednesday its estimate for the impact of tariffs in 2025, which it now expects to be around $200 million. The company’s stock is climbing in morning trading, ...

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...